Vetoquinol S.A. (VETO.PA) stock: Winston Score, insiders and Congress trades

Vetoquinol is a French company that makes medicines and health products for animals. Its main customers are veterinarians, farmers, and pet owners. The company focuses on companion animals like dogs and cats, as well as livestock such as cattle and pigs, and it sells products including antibiotics, anti-inflammatories, and nutritional supplements. Vetoquinol earns money by selling these veterinary products directly to vets and through distributors. It operates in over 30 countries, with a strong presence in Europe, North America, and emerging markets, and generates roughly €500 million in annual revenue. The founding Frechin family still controls the company, which gives it a stable, long-term ownership structure, but its relatively small size means it competes against much larger players like Zoetis and Boehringer Ingelheim. The key growth driver is the continued rise in pet ownership globally, though pricing pressure from generic competitors and currency fluctuations remain ongoing risks.

Editorial rules set and reviewed by Felix Prehn, Economist and Editor. Figures are refreshed daily from Financial Modeling Prep and company filings; last refreshed 2026-10-11.